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Introduction
• Scleroderma and systemic sclerosis are 
autoimmune phenomena that can cause progressive 
and permanent damage to the organs of the human 
body. 
• They can cause fibrosis of various internal organs, 
including the kidneys, lungs, GI tract, and heart
• Rarely, the only manifestation of systemic sclerosis 
is severe hypertension with renal failure, a subset 
known as systemic sclerosis sine scleroderma.
Case Presentation
• In this case report, a 39-year-old Hispanic female 
with a past medical history of GERD and gestational 
hypertension had presented for nausea and vomiting. 
She was a Jehovah's witness.
• Upon review of admission labs and studies from 
years prior, her chemistries had shown signs of 
progressive renal failure and proteinuria, but the 
cause of such abnormalities was never pursued. 
• On admission, she was immediately transferred to the 
intensive care unit for severe metabolic acidosis 
requiring emergent hemodialysis, treatment for 
hypertensive emergency, severe anemia, and 
electrolyte derangements. 
• Moreover, due to her religion, she declined blood 
products, so she required erythropoietin and iron 
products instead. She remained in the ICU for three 
days for severe metabolic acidosis with a chronic, 
non-oliguric nephrotic syndrome pattern. 
• Patient recovered after several sessions of 
hemodialysis and was subsequently started on tri-
weekly sessions of hemodialysis.
Results
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Conclusion
• This demonstrates a rare incidence of systemic sclerosis sine 
scleroderma in a patient who was positive for the Scl-70 
antibody with no skin findings.
• Several limitations, including religious beliefs, reduced the 
scope of a full investigation and treatment options.
• It also highlights the importance of pursuing abnormalities on 
routine blood studies because it can ultimately prevent 
irreversible kidney damage and can aide in anticipating 
further internal organ involvement.
Characteristics
• An extensive immune panel was positive for the 
antinuclear antibody, the Scl-70 antibody, and low C3. A 
biopsy was not attempted because the patient's 
hemoglobin was too unstable at the time.
• On admission, labs were: Hb 7.2, K  3.1, HCO3-14, 
BUN 111, Cr 17.9,  GFR  2, Ca2+ < 5, Ph 8.3, and severe 
proteinuria in the urine. Previous outpatient labs showed 
a Cr of 1.2 in 2015, Cr of 1.7 in 2017 with stage 3B 
CKD, and increasing proteinuria between 2014 and 2017 
that was never pursued.
Figure 1: Clinical manifestations commonly found in systemic sclerosis (Montrief).
Figure 2: The hallmark of scleroderma renal crisis is a proliferative, obliterative arteriolar 
vasculopathy with (a) hypertensive vascular damage, thrombotic vascular occlusion, 
glomerular ischaemic collapse, and diffuse tubular degeneration (b), onion skinning, and (c) 
intimal myoid accumulation and adventitial fibrosis (Woodroth).
